The evolutionary fate of humans is intimately linked with that of our microbiome. Medical and technological advances have caused large-scale changes in the composition and maturation of humanassociated microbial communities, increasing our susceptibility to infectious and developmental diseases. Restoration of the human microbiome must become a priority for biomedicine.
In the beginnings of life on Earth, bacteria were alone. As multicellular organisms arose over the eons, they fought some bacteria and adapted to living with others that colonized external and internal surfaces. From invertebrates to mammals, these microbial consortia have not evolved strictly at random; sequence analyses provide evidence for extensive sympatry between hosts and their colonizing microbial populations, indicating longstanding co-evolution. These microbes have an evolutionary stake in keeping their hosts alive; their conservation is an indication of their functional benefits. Together, the host and its microbes form a ''holobiont,'' an emergent property in which the whole exceeds the sum of its parts, based on the added dimension of co-evolution over time. This simple concept underlies human biology.
The sympatry between hosts and their microbes implies strong vertical transmission (Moeller et al., 2016) . Thus, the roots of the microbiome in each individual lay in the preceding generation, and the mother transmits her microbes to her offspring. During microbiological youth, including at least the first 3 years of life (Yatsunenko et al., 2012) , we acquire the microbial populations that support our development, leading to the ultimate reproduction of ourselves and our microbes. In middle-life, major microbiome functions involve homeostasis and protection from pathogens that may interfere with fecundity. Humans have a longer tail of senescence relative to most species. Although the microbiome in senescent hosts has little or no direct impact on the reproductive capacity of an individual, connections at the population level may occur through horizontal transfer of microbial communities (Blaser and Webb, 2014) . In any event, the selection for senescent age microbes must differ from the reproductive period; the microbiome changes with age both drive and reflect the aging process. In one example, Helicobacter pylori, the dominant ancestral constituent of the gastric microbiome, drives the agerelated transformation to gastric malignancy. Conversely, the microbiome lacking H. pylori promotes malignancy in the adjacent esophagus. Although the rules remain opaque, the senescent microbiome clearly contributes to the diseases of aging, including cancers and degenerative diseases (e.g., Parkinson's).
In the late 19 th century, the microbiome apparently began to change in developed countries. We can infer this based on changes in indicator organisms, like H. pylori, Oxalobacter formigenes, and the ratio between Prevotella and Bacteroides species. Perhaps this was due to cleaner drinking water and better sanitation or more directly due to chlorination. Cumulatively, the benefits of these public health practices have been enormous, contributing substantially to our improved longevity. Nevertheless, an unintended consequence has been deleterious effects on our microbiota. In the past 80 years, we have seen the introduction of antibiotics into the human biosphere on enormous scale. Practices including Cesarean-section, which interferes with the transmission of maternal microbes to the next generation, and the use of infant formula lacking the micronutrients that co-evolved to support the propagation and maintenance of ancestral microbiota, are the norm in many localities. Conversely, in present-day traditional societies in which these aspects of modernization are not present, the microbiota is substantially richer (Clemente et al., 2015; Smits et al., 2017) , consistent with the hypothesis that in industrial societies, we already have lost more than half of our microbial diversity.
Altogether, these practices have impaired both the horizontal and vertical transmission of the ancestral microbiota and the maintenance of the transmitted organisms ( Figure 1 ). We have postulated that the microbiome losses are in fact extinctions that have accumulated with the passage of generations (Blaser and Falkow, 2009) . With extinctions, the clock cannot reset with each new generation, and both observational studies comparing human populations varying in the extent of modernization (Clemente et al., 2015; Smits et al., 2017) and experimental studies (Sonnenburg et al., 2016; Schulfer et al., 2017 ) support this view.
Although differing in the year of commencement and in the extent of the perturbation by locality, these manmade changes represent a worldwide change in ecology. In many ways, it parallels the changes in macro-ecology affecting farmland, oceans, and the climate, but it is happening faster, over years and decades. In our euphoria over the successes of public health and the sometimes miraculous effects of antibiotics, we missed seeing this phenomenon until recently. Sentinel events, like the decline of our ancestral H. pylori, were considered positive because of the easily apparent benefits of its disappearance. Yet, like the proverbial canary in the coal mine, its loss is reflective of a wider decrease in microbial diversity (Clemente et al., 2015) and an altered maturation of the microbiome in early life (Bokulich et al., 2016) .
We might consider four consequences (horsemen) of the altered microbiome: facilitating antibiotic resistance, developmental diseases, middle-life illnesses, and most worrisome, epidemics.
Facilitating the Spread of Antibiotic-Resistant Organisms
Known since antibiotics were first deployed, antibiotic resistance is obviously fueled by selection for resistance genes. But another factor is that the altered microbiota has diminished ecological resistance, which in net favors retention of commensals that carry or have gained antibiotic-resistance genes. During periods in which antibiotic selection is absent (most of the time), the resistance mechanisms have metabolic costs favoring the loss of organisms carrying them. Perturbation and reduced microbial diversity lead to conditions that create new niches, lowering the net costs. By facilitating colonization by altered commensals and invasion by antibiotic-resistant pathogens, loss of ecological resistance promotes the spread of antibiotic-resistant organisms. One example is the emergence of infections by the commensal Clostridium difficile. Ecological change, e.g., induced by antibiotic exposure, removes natural competitors, allowing either endogenous or exogenous (nosocomial) C. difficile to bloom. That there has been further selection for hypertoxinogenic strains (O'Connor et al., 2009) provides an unfortunate example for the natural progression beyond the initial ecological disturbance. Paradoxically, the success of fecal transplantation in curing these infections points directly to the value of an intact ecosystem that keeps opportunists in check. Similarly, alterations of the upper respiratory microbiota may play a role in fueling antibiotic-resistant commensals/invaders (e.g., methicillin-resistant Staphylococcus aureus [MRSA] ).
Developmental Diseases
In recent years, multiple studies of children have found associations between large-scale changes to the microbiome A model is presented of altered microbiota and the consequences on early life development. (A) Influences on the early life microbiota. Assembly of the microbiome begins in mothers in the prior generation, which may have effects due to inheritance or interventions. During pregnancy and the peripartum period, a substantial fraction of mother/child dyads are exposed to perturbing effects, and postnatally, the transferred microbiota in children is subject to selection affecting their maintenance. In the model, the effects are cumulative across n generations, with decreasing diversity and increasing representation of opportunistic commensals. (B) The gastrointestinal tract as a major locus of interaction. The gut has reciprocal gradients for digestion and energy harvest (greater proximally) and energy salvage and immunity (greater distally). (C) Primary effects of perturbations on host tissues. The portal circulation affects liver and adipose tissues; the lamina propria affects lymphoid tissues and bone marrow; and the brain is affected by traffic through the vagus, hormones, and intestinal neurotransmitters. Phenotypes are complex, and just major circuits are shown, but consequences of microbiota perturbation have been observed in all named tissues. in early life (caused by activities including antibiotic use, C-sections, or formula feeding) and the later development of diseases including childhood-onset obesity, asthma, food allergies, and inflammatory bowel diseases. These epidemiologic associations are correlative only, even across numerous studies, and further do not permit exploration of whether, for example, the insult might have been the original infection for which antibiotics were prescribed or the antibiotics themselves. For this reason, experiments in model systems, including mice, are extremely useful.
Although used to mitigate the invasion of hosts by pathogens, the collateral effects of antibiotics are to uncouple the co-evolved partnership between the host and the microbiome. We can gain important insight by considering the 70-yearlong worldwide experiment on farms: early-in-life antibiotic use, even in low dose, promotes the growth of livestock, ranging from chickens to cows. One reason why antibiotics work as growth promoters-moving young hosts toward greater mass, regardless of animal species or the particular anti-bacterial used-is by upsetting developmental equilibria conserved over the eons. A proportion of nutrients in food pass undigested through the host and microbiota into the animal's wastes. By selecting for a more energy-efficient microbiota (Cho et al., 2012) , antibiotic exposure leads to a new energy source also available to the host. On the farm, animals become bigger, and a growing body of evidence supports similar phenomena in humans (Cox and Blaser, 2015) .
Similar to farm animals, mice have altered metabolism after early life exposure to antibiotics, with synergistic effects from genetic diatheses and hypercaloric diets. Antibiotic treatment of germ-free animals has shown that a microbiota is necessary for the effects, whereas microbiome transplantation to germ-free mice shows that the perturbed microbiota is sufficient for the effects (Cox et al., 2014; Ruiz et al., 2017) . Importantly, even if the perturbation is transient, consequences can be long term (Cox et al., 2014) , consistent with the general theories of development, in which early life insults lead to permanent sequelae. We know that gastric colonization with the ancestral/dominant H. pylori affects the regulation of ghrelin. Mostly produced in the stomach, ghrelin is an important hormonal player in appetite and energy homeostasis. Because of extinction, recent generations of children have been growing up without the ancestral H. pylori effects on ghrelin regulation, but we do not yet understand the consequences of this loss. Not surprisingly, by changing microbial compositions, early life antibiotic exposures also affect immunological development, particularly the context governing how adaptive responses develop from their interactions with innate immunity.
Extending the concept still further, in genetically predisposed mice, an antibiotic-perturbed microbiota in the antecedent generation led to ecological disturbances and enhanced inflammatory disease after a months-long latency in the offspring (Schulfer et al., 2017) ; a fiber-depleted diet had similar ecological effects on the microbiome across generations (Sonnenburg et al., 2016) . These studies provide evidence that perturbing the maternally transmitted microbiome can have long-term ecological and disease consequences on subsequent generations. Studies in both mice and humans show that early life exposures can cause a dysmaturity of the microbiota Schulfer et al., 2017; Bokulich et al., 2016) that can lead to disease (e.g., asthma; Stokholm et al., 2018) .
Middle-Life Illnesses
The boundaries between developmental and middle-life illnesses are imprecise, since many conditions may have developmental origins. However, there is increasing evidence that ecological disturbances due to exposures to antibiotics, other medications, specific types of diets, and food additives (artificial sweeteners, emulsifiers) may be further driving pathogenesis. For example, the incidence of kidney stones has been progressively rising, and approximately 80% of cases are calcium oxalate stones. Cross-sectional studies (e.g., Clemente et al., 2015) indicate that a member of the human microbiota, Oxalobacter formigenes, is becoming less common. Since these organisms metabolize both dietary and host-derived oxalate, their loss may be one factor that has driven the increased prevalence of oxalate kidney stones, as indicated in experimental models. For immunological diseases that have become more common in adults in the past century, including systemic lupus erythematosis, ulcerative colitis, and Crohn's disease, microbiota changes are considered as important potential antecedents for the increased incidence, but no role has been proven thus far. One possibility is that the effects of an altered microbiome (whether it be inherited, acquired early in life, or both) on early life immunological development change the context for immune responses of adults to adventitious antigenic exposures, creating a diathesis for pathogenicity.
Epidemics
Invasions are not restricted to commensals that have virulence properties but also can be due to high-grade pathogens. Macro-ecology provides numerous examples of invasive species spreading without the check of their natural competitors, using the resources of the indigenes, and ultimately choking them. In fact, this is the greatest threat of our micro-ecological changes. Invasion is a generic property and, in the human context, could be due to any microbe or virus. The critical questions concern the role of the microbiome in host resistance to invasion, the natural boundaries that curtail spread, and the resilience that allows for rapid recovery. We are already witnessing the spread of opportunistic antibiotic-resistant commensals (e.g., MRSA, vancomycin-resistant Enterococcus [VRE] , and C. difficile) in largely compromised populations but also disseminating to less-affected hosts.
With a growing and increasingly dense (urban) human population, and shortening mean travel times, we have a progressively interconnected planet. Larger contiguous populations permit the maintenance of increasingly virulent pathogens. Global micro-ecological changes make pandemics more likely. This is a horrifying concept, but we need to marshal our forces to anticipate and resist them.
Solutions
Much like recent human activities have resulted in a global carbon debt in the soil, we can think of modern sanitation and medicine having created a global human microbe debt. Is the process of loss accelerating, or is homeostasis bringing us back toward equilibrium? Although it is possible that homeostatic mechanisms may be moderating the impact of microbe depletion, the losses have been so rapid in evolutionary time that true adaptation is unlikely. Slowing the rate of loss will mitigate the extent of the burden, but how will our collective debt be repaid? Can we manage to do it slowly, gradually, or will nature do it by cataclysm? The answer is not obvious, and the stakes are high.
One hope is that we can rebuild slowly through both global and host-specific (precision) approaches. In addition to particular taxa and molecules, we must think about ecosystems and ecosystem services. In the complex and varied coevolved human microbial ecosystems, we do not yet know whether the individual molecule, gene, pathway, strain, genus, family, guild of cooperating species, or other combination is most relevant to health and disease. I suggest that each plays a role, depending on the question, and that reductionist approaches will only solve a part of the puzzle. As in other complex problems, including weather forecasting, the redundancy and sheer number of interacting and variable factors constrains the accuracy of predictions. To slow the rate of loss, we must develop narrow-spectrum antibiotics, ideally aimed at single taxa, to avoid the collateral effects of broad-spectrum antibiotics on the ''innocent bystanders'' in the microbiota. Such a goal, which is technically feasible given our increasing knowledge of microbial genomes and physiology, will also require the development and deployment of rapid microbial diagnostics to ensure that the correct agents are used.
Nevertheless, restoration will clearly be a priority. In a biological sense, first, we must weed our garden to remove the opportunistic invasive species filling the vacant niches that once were occupied, then we must re-seed with the lost indigenes. Their most likely source may be from remote present-day peoples of traditional societies in whom antibiotic use and other modern practices has been limited or absent. Perhaps we will need to fertilize these true ''probiotic'' organisms with specific prebiotics and/or with broad agents like fiber, for example, providing energy substrate to the colon. Early life seeding might have biological costs; perhaps growth will be impaired and adult height reduced, but the hope is that those children and their offspring will be healthier. Since one size will surely not fit all, we will have to develop precision approaches. Obvious recipient candidates include the babies born by C-section, those whose mother is not nursing, and those receiving early life antibiotic courses. Potential restoratives might include fecal transplants, global but crude solutions that are currently being studied for a variety of conditions. Alternatively, and more importantly, science can develop well-defined precise and individual approaches. Examples could include the restoration of particular strains of O. formigenes in patients who have had calcium oxalate kidney stones or specific strains of Bifidobacter species in children who have received antibiotics. Alternatively, we can identify specific chemical substrates (prebiotics) that such key organisms preferentially utilize and add these to the diet of the impacted individuals to rebuild depleted but still present populations. The first step is understanding the particular losses-of taxa and functions-predisposing to disease, and then we can develop specific restorative approaches. Such activities may be valuable for both prevention and treatment of disease.
Conclusions
What will future historians say about our era? Our conventional wisdom suggests that they would be impressed by our great medical advances that have prolonged both life and function for vast numbers of people. Or will they be disappointed by how we have been eroding our ancient microbial patrimony, with costs already appearing and a darkening sky ahead? We have been very conscious and appropriately proud of the advances, but now we need to pay attention to the costs. We must minimize and reverse the impact, because they threaten to undo all of our great progress in health. We urgently need to use science to solve this problem.
